Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Imagyn Laparoscopic Line Divestiture Lets Firm Focus On Oncology Devices

This article was originally published in The Gray Sheet

Executive Summary

Imagyn will use the nearly $30 mil. in proceeds from the sale of its minimal access surgery (MAS) products to Conmed to help launch three new oncology and critical care products.

You may also be interested in...

Conmed Adds Bionx To Sports Medicine Offerings, Tackling Polymer Pipeline

Conmed will continue to develop Bionx Implants' Self-Reinforced resorbable polymer technology at Bionx facilities in Blue Bell, Penn. and Tampere, Finland upon completion of its $48 mil. cash purchase of the firm, expected by this spring

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts